In summary, we have described the development of folic acid-conjugated Gd2O3:Eu3+ nanoparticles with low toxicity that can be used as a fluorescent probe for the detection of Folr1 breast cancer in vivo. The gene discussed is FOLR1; the disease is breast carcinoma.